# Werewolf Therapeutics, Inc. (HOWL) - Q2 2026 earnings

Reported July 31, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $21.0M | $21.0M |
| EPS | $0.08 | $-0.28 |

Earnings filing reader: [8-K 0001785530-26-000018](https://www.opencapital.sh/filings/0001785530-26-000018)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001785530-26-000018.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1785530/000178553026000018/0001785530-26-000018-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1785530/000178553026000019/0001785530-26-000019-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/howl/earnings/q2-2026